Koninklijke Philips (PHG) Interest & Investment Income (2009 - 2026)
Koninklijke Philips' (PHG) quarterly Interest & Investment Income came in at $41.0 million in Q1 2026, up 18.05% year-on-year from $34.7 million in Q1 2025, and down 7.36% quarter-over-quarter from $44.2 million in Q4 2025.
Koninklijke Philips (PHG) Interest & Investment Income (2009 - 2026) Analysis & Trends
Koninklijke Philips' Interest & Investment Income history runs 18 years deep, the most recent figure standing at $41.0 million for Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 18.05% year-over-year to $41.0 million in Q1 2026; TTM through Mar 2026 was $172.0 million, a 38.91% increase from a year earlier, with the FY2025 full-year figure at $131.5 million, up 17.23% from the prior year.
- Interest & Investment Income fell to $41.0 million in Q1 2026 per PHG's latest filing, from $44.2 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $81.3 million in Q3 2024 and bottomed at -$40.6 million in Q4 2024.
- The 5-year median for Interest & Investment Income is $26.1 million (2024), against an average of $29.7 million.
- Biggest YoY gain for Interest & Investment Income was 397.7% in 2024; the steepest drop was 1358.02% in 2024.
- Year by year, Interest & Investment Income stood at $14.3 million in 2022, then tumbled by 77.4% to $3.2 million in 2023, then tumbled by 1358.02% to -$40.6 million in 2024, then surged by 208.93% to $44.2 million in 2025, then fell by 7.36% to $41.0 million in 2026.
- Per Business Quant, the three latest PHG Interest & Investment Income figures stand at $41.0 million (Q1 2026), $44.2 million (Q4 2025), and $24.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.98 Mn |
| Dec 31, 2025 | 44.23 Mn |
| Sep 30, 2025 | 24.55 Mn |
| Jun 30, 2025 | 62.26 Mn |
| Mar 31, 2025 | 34.71 Mn |
| Dec 31, 2024 | -40.61 Mn |
| Sep 30, 2024 | 81.27 Mn |
| Jun 30, 2024 | 48.46 Mn |
| Mar 31, 2024 | 26.07 Mn |
| Dec 31, 2023 | 3.23 Mn |
| Sep 30, 2023 | 16.33 Mn |
| Jun 30, 2023 | 33.76 Mn |
| Mar 31, 2023 | 15.03 Mn |
| Dec 31, 2022 | 14.28 Mn |
| Sep 30, 2022 | 60.50 Mn |
| Jun 30, 2022 | 21.34 Mn |
| Mar 31, 2022 | 19.08 Mn |
| Dec 31, 2021 | 170.45 Mn |
| Sep 30, 2021 | 134.44 Mn |
| Jun 30, 2021 | 90.32 Mn |